Novacyt introduces new COVID-19 testing products

Novacyt has launched Exsig Direct, Exsig Mag and COVID-HT to support labs testing for COVID-19. The first two new products are RNA extraction kits for use prior to running a polymerase chain reaction test for COVID-19 where Exsig Direct improves lab workflow, reduces cycle times, increases throughput by up to 50% and reduces costs, and Exsig Mag enhances extraction of COVID-19 RNA from clinical samples and, when used in combination with the company’s COVID-19 test, offers ultra-sensitive detection of COVID-19. The third product is a CE mark test for use in labs performing high volumes of tests and was designed to perform at the same high levels of specificity and sensitivity as the company’s existing COVID-19 test, thus improving operational efficiency and saving time and labour associated with handling and preparing the test for use.

Group CEO of Novacyt, Graham Mullis, said: “As we continue to supply our COVID-19 test to laboratories around the world, we are delighted to provide further support through the launch of these new products. We believe there will be significant demand for our new extraction kits, particularly at this time when automated RNA extraction reagents are in short supply. In addition, our high-throughput test, for use in large volume clinical laboratories, should enable more efficient workflow which is critical to achieve optimal testing volumes. We look forward to continuing to work with our customers to support their testing requirements through new and innovative solutions.”